Rafael Holdings Inc
NYSE:RFL
Intrinsic Value
Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. [ Read More ]
The intrinsic value of one RFL stock under the Base Case scenario is 0.058 USD. Compared to the current market price of 1.695 USD, Rafael Holdings Inc is Overvalued by 97%.
Valuation Backtest
Rafael Holdings Inc
Run backtest to discover the historical profit from buying and selling RFL stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Rafael Holdings Inc
Current Assets | 75.1m |
Cash & Short-Term Investments | 71.7m |
Receivables | 2.9m |
Other Current Assets | 487k |
Non-Current Assets | 31.1m |
Long-Term Investments | 21.9m |
PP&E | 2.1m |
Intangibles | 7m |
Other Non-Current Assets | 42k |
Current Liabilities | 3.3m |
Accounts Payable | 578k |
Accrued Liabilities | 845k |
Short-Term Debt | 1.7m |
Other Current Liabilities | 140k |
Non-Current Liabilities | -2.1m |
Other Non-Current Liabilities | -2.1m |
Earnings Waterfall
Rafael Holdings Inc
Revenue
|
276k
USD
|
Operating Expenses
|
-11.5m
USD
|
Operating Income
|
-11.3m
USD
|
Other Expenses
|
13.5m
USD
|
Net Income
|
2.2m
USD
|
Free Cash Flow Analysis
Rafael Holdings Inc
RFL Profitability Score
Profitability Due Diligence
Rafael Holdings Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
Score
Rafael Holdings Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.
RFL Solvency Score
Solvency Due Diligence
Rafael Holdings Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Rafael Holdings Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RFL Price Targets Summary
Rafael Holdings Inc
Ownership
RFL Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
RFL Price
Rafael Holdings Inc
Average Annual Return | -25.86% |
Standard Deviation of Annual Returns | 52.77% |
Max Drawdown | -98% |
Market Capitalization | 41.5m USD |
Shares Outstanding | 24 580 000 |
Percentage of Shares Shorted | 0.2% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 23 full-time employees. The company went IPO on 2018-03-12. The firm operates through two segments: Pharmaceuticals and Real Estate. The Pharmaceuticals segment is comprised of preferred and common equity interests and the Warrant to purchase equity interests in Rafael Pharmaceuticals, a majority equity interest in LipoMedix, Barer, Levco, Farber and Rafael Medical Devices. The Real Estate segment consists of the Company's real estate holdings, including a building at 520 Broad Street in Newark, New Jersey that houses headquarters for the Company and certain affiliates and its associated public garage and a portion of an office building in Israel.
Contact
IPO
Employees
Officers
The intrinsic value of one RFL stock under the Base Case scenario is 0.058 USD.
Compared to the current market price of 1.695 USD, Rafael Holdings Inc is Overvalued by 97%.